Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Eric who wrote (1424231)	11/6/2023 1:25:23 PM
From: Broken_Clock	Read Replies (1) \| Respond to of 1578884

"So did any other scientists in virology chime in? I have a neighbor just down the street that is a senior virologist (teaching doc) at the University of Washington School of Medcine who actually evaluated the Moderna and Pfizer vaccines before they were released to the public. She handled phase three trials here in the PNW." Interesting...now back to the topic... Which is potential gene alteration, not virology. As noted on this and other threads repeatedly, the "vaccines" never were...these are a totally new field called gene therapy. Mr. McKernan, a former researcher and team leader for the Massachusetts Institute of Technology Human Genome Project, noted that scientists have found that SV40 sequences are optimal for gene therapy and that one paper described a rate of insertional mutagenesis with transfection being as high as 7 percent of the modified cells. Of note, I was talking to a guy at Home Depot and he said your friend should stick to what she knows.